MoonLake Immunotherapeutics (MLTX)
39.74
-1.12
(-2.74%)
USD |
NASDAQ |
May 17, 16:00
39.74
0.00 (0.00%)
After-Hours: 20:00
MoonLake Immunotherapeutics Accounts Payable (Quarterly): 1.630M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.630M |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 |
| Date | Value |
|---|---|
| December 31, 2022 | |
| September 30, 2022 | 0.1555M |
| June 30, 2022 | 0.2467M |
| December 31, 2021 | 1.233M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.1555M
Minimum
Sep 2022
1.630M
Maximum
Mar 2024
0.8163M
Average
0.7399M
Median
Accounts Payable (Quarterly) Benchmarks
| Qiagen NV | 75.33M |
| LENZ Therapeutics Inc | 7.131M |
| AC Immune SA | 3.144M |
| CRISPR Therapeutics AG | 16.46M |
| Addex Therapeutics Ltd | 1.172M |